PRKCF yields 563.38% · JNJ yields 2.14%● Live data
📍 PRKCF pulled ahead of the other in Year 1
Combined, PRKCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRKCF + JNJ for your $10,000?
Parker Corporation provides product development, manufacturing, sales, and technical services for the automobiles, electrical machinery, chemicals, steel, electronics, food, etc. industries in Japan and internationally. The company imports and sells machinery and equipment for use in automobile, food, shoemaking, and chemical industries. It also develops, manufactures, and sells fine chemicals for industrial use, such as cleaning agents, rust prevention, etc.; and chemical products centered on advanced chemicals, such as electronics and printing, as well as special chemicals for the aftermarket of car, railways, and aircraft. In addition, the company develops and sells industrial sealing materials and adhesives; and manufactures and sells soundproofing materials for automobile and air conditioners. Further, it develops, designs, manufactures, and sells industrial machinery. The company was formerly known as Parker Shoji Co., Ltd. and changed its name to Parker Corporation in August 1988. Parker Corporation was founded in 1951 and is headquartered in Tokyo, Japan.
Full PRKCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.